We demonstrate that an early infusion of MoAb reduces the risk of severe COVID-19 having a 10-fold lesser risk of admission to ICUs and death and, consequently, strongly comforts preliminary results reported in SOT recipients without major side effects

Posted on by Courtney Roberts

We demonstrate that an early infusion of MoAb reduces the risk of severe COVID-19 having a 10-fold lesser risk of admission to ICUs and death and, consequently, strongly comforts preliminary results reported in SOT recipients without major side effects.11, 12, 13 This remarkable effectiveness of MoAb is the result of Continue Reading